AI and Human Intuition in Drug Discovery

Artificial intelligence (AI) is transforming the drug discovery process by enabling rapid analysis of complex biological data, predicting drug-target interactions, optimizing lead compounds, and accelerating candidate selection. However, human intuition, scientific expertise, and clinical judgment remain essential components of successful pharmaceutical innovation. This article explores the complementary relationship between AI-driven technologies and human decision-making in modern drug discovery. While AI excels at identifying patterns, processing large datasets, and generating predictive models, researchers contribute critical contextual understanding, creativity, ethical oversight, and the ability to interpret findings within broader biological and clinical frameworks. The integration of AI with human expertise can improve research efficiency, reduce development costs, and enhance the identification of promising therapeutic candidates. The article highlights current applications, challenges, and future opportunities associated with this collaborative approach, emphasizing that the most effective drug discovery strategies combine computational intelligence with human insight to advance innovative and patient-centered therapies.